Symptom Identification and Management in Patients With Hematological Malignancy During Follow-up Care

NACompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

February 8, 2021

Primary Completion Date

February 1, 2023

Study Completion Date

February 1, 2023

Conditions
Hematologic Malignancy
Interventions
OTHER

HM-PRO

"The intervention group will have a predetermined consultation appointment planned to assess medical status and symptom control. Seven days prior to the scheduled visit, the patient will receive an electronic invitation via RedCap to complete and send PRO data (HM-PRO). Prior to each appointment PRO data will be evaluated by a nurse from an algorithm deciding one of three tracks for the patients:~1. Worsening in symptoms results in a nurse-led telephone consultation within two days guided by the symptom management manual.~2. Minor changes in patient's symptom assessment result in a nurse-led telephone consultation within seven days using the symptom management manual.~3. Patients that are completely stable in the symptom assessment will receive an electronic answer via min-SP (electronic patient journal) regarding the results and a new appointment, including PRO-data prior to this."

Trial Locations (1)

2100

Dept. of Hematology, Copenhagen

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novo Nordisk A/S

INDUSTRY

lead

Rigshospitalet, Denmark

OTHER